Fas ligand (monomer)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784742/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784742/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784741/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784741/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784740/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784740/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878473f/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878473f/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878473e/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878473e/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878473d/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878473d/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878473c/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878473c/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878473b/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878473b/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878473a/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878473a/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784739/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784739/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784738/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784738/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784737/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784737/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784736/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784736/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784735/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784735/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784734/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784734/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784733/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784733/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784732/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784732/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784731/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784731/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784730/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784730/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878472f/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878472f/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878472e/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878472e/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878472d/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878472d/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878472c/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878472c/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878472b/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878472b/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878472a/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878472a/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784729/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784729/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784728/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784728/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784727/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784727/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784726/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784726/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784725/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784725/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784724/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784724/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784723/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784723/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784722/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784722/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784721/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784721/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf0028784720/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf0028784720/fas-ligand-monomer.png"},{"image":"https://icons.biorender.com/w75xh75/5f22e238f0d8bf002878471f/fas-ligand-monomer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f22e238f0d8bf002878471f/fas-ligand-monomer.png"}]
Keywords
fas,ALPS1A,APO-1,APT1,CD95,FAS1,FASTTM,TNFRSF6,tnfr,tumor necrosis factor super family,monoclonal antibody,ligand,fas